Microbiome-Derived Lipid Nanoparticles for Improved Immunogenicity of mRNA Vaccines-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Microbiome-Derived Lipid Nanoparticles for Improved Immunogenicity of mRNA Vaccines

Published:2024-03-21 Issue:4 Volume:6 Page:1557-1563
ISSN:2639-4979
Container-title:ACS Materials Letters
language:en
Short-container-title:ACS Materials Lett.

Author:

Yong Seok-Beom¹^ORCID,Park Ok Hyun¹,Cho Sungchan¹²

Affiliation:

1. Nucleic Acid Therapeutics Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon 28116, Chungcheongbuk-do, Republic of Korea

2. Department of Biomolecular Science, KRIBB School of Bioscience, Korea University of Science and Technology (KUST), Daejeon 34113, Republic of Korea

Funder

Korea Health Industry Development Institute

Korea Research Institute of Bioscience and Biotechnology

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acsmaterialslett.3c01642

Reference30 articles.

1. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

2. Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer

3. A single-dose F1-based mRNA-LNP vaccine provides protection against the lethal plague bacterium

4. Development of an mRNA-lipid nanoparticle vaccine against Lyme disease

5. A TLR7-nanoparticle adjuvant promotes a broad immune response against heterologous strains of influenza and SARS-CoV-2

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP